Division of Hand, Plastic and Aesthetic Surgery, University Hospital, LMU Munich, Ziemssenstraße 5, 80336, Munich, Germany.
Department of Plastic Surgery and Hand Surgery, University Hospital Zurich, Zürich, Switzerland.
Aesthetic Plast Surg. 2023 Dec;47(6):2771-2787. doi: 10.1007/s00266-023-03511-y. Epub 2023 Aug 10.
While autologous fat grafting of the face is considered a generally safe procedure, severe complications such as arterial embolism (AE) have been reported.
To summarize data on injection-related visual compromise, stroke, and death caused by arterial embolism after facial fat transplantation.
Plastic surgery societies were contacted for reports on AE after autologous facial fat injection. In addition, a systematic literature review was performed. Data extracted included study design, injection site/technique, symptoms, management, outcome, and etiology.
61 patients with a mean age of 33.56 ± 11.45 years were reported. Injections targeted the glabella or multiple facial regions (both n = 16/61, 26.2%) most commonly, followed by injections in the temples (n = 10/61, 16.4%) and the forehead (n = 9/61, 14.8%). The mean volume injected was 21.5 ± 21.5 ml. Visual symptoms were described most frequently (n = 24/58, 41.4%) followed by neurological symptoms (n = 20/58, 34.5%), or both (n = 13/58, 22.4%). Ophthalmic artery (OA, n = 26/60, 43.3%), anterior or middle cerebral artery (CA, n = 11/60, 18.3%) or both (n = 14/60, 23.3%) were most frequently occluded. Outcome analysis revealed permanent vision loss in all patients with OA occlusion (n = 26/26, 100%), neurological impairment in most patients with CA occlusion (n = 8/10, 80%), and vision loss in most patients suffering from both OA and CA occlusion (n = 7/11, 63.6%). Six patients died following embolisms.
AE causes severe complications such as blindness, stroke, and death. Due to a lack of high-quality data, no evidence-based treatment algorithms exist. To increase patient safety, a database collecting cases and complications should be established.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
虽然自体脂肪移植面部被认为是一种相对安全的手术,但已有严重并发症(如动脉栓塞)的报道。
总结因面部脂肪移植后动脉栓塞引起的与注射相关的视力障碍、中风和死亡病例的数据。
联系整形外科学会报告自体面部脂肪注射后的动脉栓塞病例。此外,还进行了系统的文献回顾。提取的数据包括研究设计、注射部位/技术、症状、处理、结果和病因。
报告了 61 例患者,平均年龄为 33.56±11.45 岁。最常见的注射部位是眉间或多个面部区域(各 16/61,26.2%),其次是太阳穴(10/61,16.4%)和前额(9/61,14.8%)。平均注射量为 21.5±21.5ml。最常描述的是视觉症状(24/58,41.4%),其次是神经症状(20/58,34.5%),或两者兼有(13/58,22.4%)。最常闭塞的是眼动脉(26/60,43.3%)、前或大脑中动脉(11/60,18.3%)或两者(14/60,23.3%)。结果分析显示,眼动脉闭塞(26/26,100%)的所有患者均出现永久性视力丧失,大脑中动脉闭塞(8/10,80%)的多数患者出现神经功能障碍,眼动脉和大脑中动脉均闭塞(7/11,63.6%)的多数患者出现视力丧失。6 例患者在栓塞后死亡。
动脉栓塞可导致失明、中风和死亡等严重并发症。由于缺乏高质量的数据,目前尚无循证治疗方案。为了提高患者安全性,应建立一个收集病例和并发症的数据库。
证据等级 III:本刊要求作者为每篇文章指定一个证据等级。有关这些循证医学等级的完整描述,请参考目录或在线作者指南 www.springer.com/00266。